Sopartec

CISSOID is a Fabless Semiconductor company, leader in High Temperature Electronics. They develop and sell Integrated Circuits (IC) designed for the highest reliability in the widest range of temperatures. Their products will operate at least from -55°C to +225°C. They have been tested from -200°C to +300°C. The reliability of CISSOID products is based on long years of experience in silicon technologies, design for reliability, assembly techniques and test. CISSOID products are commonly used under extreme conditions and harsh environments, for example in demanding Oil&Gas, Aerospace and Automotive applications. They enable exploitation of deep oil resources, energy savings in aircrafts and automobiles, optimal exploitation of geothermal resources, etc. CISSOID proposes a portfolio of High Temperature standard products, such as Voltage Regulators, Voltage References, Clock Generators & Timers, Analog-to-Digital Converters, Amplifiers, High-Voltage MOSFET's and Drivers. Custom solutions can also be developed as an Application Specific Monolithic IC (ASIC) or as a Hybrid multichip assembly solution. Most of CISSOID’s products are built on Silicon-on-Insulator (SOI), a fabrication process that offers tremendous advantages for High Temperature operation and high levels of radiation (Rad-Hard products). Cissoid’s products inherit over 20 years of R&D activities in the field of SOI and was the very first company to exploit this technology. CISSOID produces: DC-DC converters (High Temperature) Linear Voltage Regulators (High Temperature) MOSFET and Switches (High Temperature) Oscillators and Timers (High Temperature) Motor Drivers ((High Temperature) Logic Gates (High Temperature) Operational Amplifiers (High Temperature) Analog-to-DIgital Converters (High Temperature)

VIRIDAXIS, a spin‑off of Louvain Catholic University, uses an innovative technology to mass-produce parasitoids. These are then supplied to Belgian and multinational companies operating in this sector. Expansion of its R&D activity now enables the company to develop new products and increase its production capacity.

Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA. Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and drug candidates through a strategy of license acquisitions as well as an internal research and development activity based on its prodrug technologies, Vectocell® and Tumor-Selective Prodrug (TSP).